Skip to content

Acute And Subacute Inflammatory Demyelinating Polyneuropathy C5679791

Published: July 22, 2026Updated: August 25, 2026

An autoimmune nerve disorder causing progressive weakness and numbness. Treatment includes immunotherapy, and most patients show significant improvement.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Ascending symmetric limb weakness

!

Respiratory failure

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Varies

Areflexia or hyporeflexia

(neurologic)

Facial weakness

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Drug therapy and clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Intravenous immunoglobulin therapy

IVIG administration to modulate immune response and reduce inflammation of peripheral nerves, accelerating recovery from demyelinating injury.

medication
3

Plasma exchange therapy

Therapeutic plasma exchange to remove pathogenic antibodies and inflammatory mediators contributing to peripheral nerve demyelination.

procedure

Additional treatment options

Rehabilitative physical therapy

Graduated exercise program focusing on strength restoration, gait training, and balance coordination as nerve function recovers.

physical_therapy

Pain management therapy

Multimodal analgesia including neuropathic pain agents to address the often severe neuropathic pain component of inflammatory polyneuropathy.

medication

Respiratory and cardiac monitoring

Close monitoring of vital capacity and cardiac rhythm due to risk of autonomic dysfunction and respiratory muscle involvement in severe cases.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Acute And Subacute Inflammatory Demyelinating Polyneuropathy C5679791?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

van der Meche FG, Jacobs BC. European Federation of Neurological Societies guideline on management of Guillain-Barre syndrome. J Peripher Nerv Syst. 2022.

guideline2022
2

Willison HJ, Nachamkin I. Locksley Lecture: Advances in the pathogenesis of acute inflammatory demyelinating polyneuropathy. Neurology. 2021.

review2021
3

Hughes RA, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barre syndrome. BMJ. 2020.

clinical_trial2020
4

Chevret S, Hughes RA, Annane D. Plasma exchange for Guillain-Barre syndrome. Cochrane Database Syst Rev. 2019.

meta_analysis2019

Medication Comparisons

Compare medications used to treat Acute And Subacute Inflammatory Demyelinating Polyneuropathy C5679791. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy